Alessandro Leal, Natalie Klar, Apoorvi Tyagi, Farbod Darvishian, Maryann Kwa, Marleen Meyers, Yelena Novik, Ruth Oratz, Anastasia Zhurova, Cindy Loomis, Douglas Kanter Marks, Iryna Voloshyna, Michelle Krogsgaard, Sylvia Adams. "Immunotherapy vs. chemotherapy run-in followed by pembrolizumab plus nab-paclitaxel in metastatic triple negative breast cancer (mTNBC): Results from a phase II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1112